These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1968671)

  • 21. Combined MAOI-tricyclic antidepressant treatment: a reevaluation.
    White K; Simpson G
    J Clin Psychopharmacol; 1981 Sep; 1(5):264-82. PubMed ID: 7037873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressant discontinuation syndromes.
    Haddad PM
    Drug Saf; 2001; 24(3):183-97. PubMed ID: 11347722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D; Silver JM; Opler LA
    J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyramine and new monoamine oxidase inhibitor drugs.
    Simpson GM; de Leon J
    Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential adverse effects of discontinuing psychotropic drugs: part 2: antidepressant drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Jul; 48(7):9-12. PubMed ID: 20608581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
    Oostervink F; Bouvy PF; Touw DJ
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1937-40. PubMed ID: 14574773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are the newer antidepressant drugs as effective as established physical treatments? Results from an Australasian clinical panel review.
    Parker G; Mitchell P; Wilhelm K; Menkes D; Snowdon J; Schweitzer I; Grounds D; Skerritt P; Roy K; Hadzi-Pavlovic D
    Aust N Z J Psychiatry; 1999 Dec; 33(6):874-81. PubMed ID: 10619215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myoclonic seizures after abrupt withdrawal from phenelzine and alprazolam.
    Naylor MW; Grunhaus L; Cameron O
    J Nerv Ment Dis; 1987 Feb; 175(2):111-4. PubMed ID: 3806075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy in older depressed patients.
    Fann WE
    J Gerontol; 1976 May; 31(3):304-10. PubMed ID: 5482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative Effectiveness of Monoamine Oxidase Inhibitor and Tricyclic Antidepressant Combination Therapy for Treatment-Resistant Depression.
    Amsterdam JD; Kim TT
    J Clin Psychopharmacol; 2019; 39(6):649-652. PubMed ID: 31688401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of obesity by psychotropic drugs.
    Bernstein JG
    Ann N Y Acad Sci; 1987; 499():203-15. PubMed ID: 2886102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychotherapeutic drugs: important adverse reactions and interactions.
    Burrows GD; Norman TR
    Drugs; 1980 Dec; 20(6):485-93. PubMed ID: 6110534
    [No Abstract]   [Full Text] [Related]  

  • 34. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death.
    Kline SS; Mauro LS; Scala-Barnett DM; Zick D
    Clin Pharm; 1989 Jul; 8(7):510-4. PubMed ID: 2568897
    [No Abstract]   [Full Text] [Related]  

  • 35. Tranylcypromine withdrawal phenomena.
    Halle MT; Dilsaver SC
    J Psychiatry Neurosci; 1993 Jan; 18(1):49-50. PubMed ID: 8461282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combining a classic monoamine oxidase inhibitor with a tricyclic antidepressant in therapy-resistant depression: a case report and literature review].
    Schipper P; Vanmolkot L; Peeters FP
    Tijdschr Psychiatr; 2016; 58(12):886-890. PubMed ID: 27976787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The risk of neuroleptic discontinuation in schizophrenia].
    Jarema M
    Psychiatr Pol; 1999; 33(1):69-81. PubMed ID: 10786216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1976 Oct; 18(22):89-96. PubMed ID: 10519
    [No Abstract]   [Full Text] [Related]  

  • 39. The Newcastle Anxiety Depression Diagnostic Index in relationship to the effects of monoamine oxidase inhibitors and tricyclic antidepressants.
    Davidson J; Pelton S; Krishnan RR; Allf B
    J Affect Disord; 1986; 11(1):51-8. PubMed ID: 2944928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute poisoning by new psychotropic drugs].
    Harry P
    Rev Prat; 1997 Apr; 47(7):731-5. PubMed ID: 9183949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.